JP2010259438A5 - - Google Patents

Download PDF

Info

Publication number
JP2010259438A5
JP2010259438A5 JP2010139230A JP2010139230A JP2010259438A5 JP 2010259438 A5 JP2010259438 A5 JP 2010259438A5 JP 2010139230 A JP2010139230 A JP 2010139230A JP 2010139230 A JP2010139230 A JP 2010139230A JP 2010259438 A5 JP2010259438 A5 JP 2010259438A5
Authority
JP
Japan
Prior art keywords
tumor suppressor
sample
suppressor gene
determining
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010139230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010259438A (ja
JP5202583B2 (ja
Filing date
Publication date
Priority claimed from US08/791,115 external-priority patent/US6262242B1/en
Application filed filed Critical
Publication of JP2010259438A publication Critical patent/JP2010259438A/ja
Publication of JP2010259438A5 publication Critical patent/JP2010259438A5/ja
Application granted granted Critical
Publication of JP5202583B2 publication Critical patent/JP5202583B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2010139230A 1997-01-30 2010-06-18 Ts10q23.3と称する腫瘍抑制因子 Expired - Lifetime JP5202583B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/791,115 US6262242B1 (en) 1997-01-30 1997-01-30 Tumor suppressor designated TS10Q23.3
US08/791,115 1997-01-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008184139A Division JP4768783B2 (ja) 1997-01-30 2008-07-15 Ts10q23.3と称する腫瘍抑制因子

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013006918A Division JP2013128485A (ja) 1997-01-30 2013-01-18 Ts10q23.3と称する腫瘍抑制因子

Publications (3)

Publication Number Publication Date
JP2010259438A JP2010259438A (ja) 2010-11-18
JP2010259438A5 true JP2010259438A5 (enExample) 2011-09-08
JP5202583B2 JP5202583B2 (ja) 2013-06-05

Family

ID=25152739

Family Applications (5)

Application Number Title Priority Date Filing Date
JP53289798A Withdrawn JP2001511002A (ja) 1997-01-30 1998-01-08 Ts10q23.3と称する腫瘍抑制因子
JP2008184139A Expired - Lifetime JP4768783B2 (ja) 1997-01-30 2008-07-15 Ts10q23.3と称する腫瘍抑制因子
JP2010139230A Expired - Lifetime JP5202583B2 (ja) 1997-01-30 2010-06-18 Ts10q23.3と称する腫瘍抑制因子
JP2013006918A Withdrawn JP2013128485A (ja) 1997-01-30 2013-01-18 Ts10q23.3と称する腫瘍抑制因子
JP2014040353A Withdrawn JP2014155493A (ja) 1997-01-30 2014-03-03 Ts10q23.3と称する腫瘍抑制因子

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP53289798A Withdrawn JP2001511002A (ja) 1997-01-30 1998-01-08 Ts10q23.3と称する腫瘍抑制因子
JP2008184139A Expired - Lifetime JP4768783B2 (ja) 1997-01-30 2008-07-15 Ts10q23.3と称する腫瘍抑制因子

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013006918A Withdrawn JP2013128485A (ja) 1997-01-30 2013-01-18 Ts10q23.3と称する腫瘍抑制因子
JP2014040353A Withdrawn JP2014155493A (ja) 1997-01-30 2014-03-03 Ts10q23.3と称する腫瘍抑制因子

Country Status (14)

Country Link
US (1) US6262242B1 (enExample)
EP (2) EP0972024B2 (enExample)
JP (5) JP2001511002A (enExample)
AR (1) AR011607A1 (enExample)
AT (1) ATE499444T1 (enExample)
AU (1) AU745296B2 (enExample)
CA (1) CA2278849C (enExample)
DE (1) DE69842141D1 (enExample)
DK (1) DK0972024T4 (enExample)
ES (1) ES2361044T5 (enExample)
IL (1) IL131168A0 (enExample)
PT (1) PT972024E (enExample)
WO (1) WO1998033907A1 (enExample)
ZA (1) ZA98756B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287854B1 (en) 1996-10-22 2001-09-11 Imperial Cancer Research Technology Limited Diagnosis of susceptibility to cancer and treatment thereof
US6482795B1 (en) 1997-01-30 2002-11-19 Myriad Genetics, Inc. Tumor suppressor designated TS10q23.3
WO1998034624A1 (en) * 1997-02-07 1998-08-13 The Trustees Of Columbia University In The City Of New York Use of the p-ten suppressor gene in diagnosis and treatment of cancer
US6225120B1 (en) 1997-05-15 2001-05-01 The General Hospital Corporation Therapeutic and diagnostic tools for impaired glucose tolerance conditions
US6861256B2 (en) 1997-05-15 2005-03-01 The General Hospital Corporation Therapeutic and diagnostic tools for impaired glucose tolerance conditions
WO1999002704A2 (en) * 1997-07-08 1999-01-21 Cold Spring Harbor Laboratory Dual specifically phosphatase and methods of use
DE69830596T2 (de) * 1997-08-26 2006-03-16 Board of Regents, The University of Texas System, Austin Ein tumorsuppressor namens ts10q23.3
WO2002040544A2 (en) 2000-11-14 2002-05-23 Board Of Regents, University Of Texas Systems Mutant human factor ix with an increased resistance to inhibition by heparin
WO2003054512A2 (en) * 2001-12-20 2003-07-03 Tularik Inc. Identification of an amplified gene and target for drug intervention
EP1756137A4 (en) * 2003-11-05 2007-10-31 Univ Texas DIAGNOSTIC AND THERAPEUTIC PROCEDURES AND COMPOSITIONS CONCERNING PTEN AND BREAST CANCER
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
CN103424541B (zh) 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
EP3216874A1 (en) 2008-09-05 2017-09-13 TOMA Biosciences, Inc. Methods for stratifying and annotating cancer drug treatment options
WO2010056337A2 (en) 2008-11-12 2010-05-20 Caris Mpi, Inc. Methods and systems of using exosomes for determining phenotypes
CN103237901B (zh) 2010-03-01 2016-08-03 卡里斯生命科学瑞士控股有限责任公司 用于治疗诊断的生物标志物
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
IN2013MN00522A (enExample) 2010-09-24 2015-05-29 Univ Leland Stanford Junior
BR112014013544A2 (pt) 2011-12-30 2017-06-13 Abbott Molecular Inc materiais e métodos para diagnose, prognose e avaliação do tratamento terapêutico/profilático de câncer da próstata

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
EP0273085A1 (en) 1986-12-29 1988-07-06 IntraCel Corporation A method for internalizing nucleic acids into eukaryotic cells
AU622104B2 (en) 1987-03-11 1992-04-02 Sangtec Molecular Diagnostics Ab Method of assaying of nucleic acids, a reagent combination and kit therefore
FR2616841A1 (fr) 1987-06-17 1988-12-23 Rauner Hans Perfectionnements au systeme de bloquage en position ouverte a levier de serrage pivotant, pour fiches et paumelles de portes et de fenetres
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
ATE92538T1 (de) 1988-01-21 1993-08-15 Genentech Inc Verstaerkung und nachweis von nukleinsaeuresequenzen.
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US4932207A (en) 1988-12-28 1990-06-12 Sundstrand Corporation Segmented seal plate for a turbine engine
US5279721A (en) 1993-04-22 1994-01-18 Peter Schmid Apparatus and method for an automated electrophoresis system
CN1203633A (zh) 1995-10-23 1998-12-30 帝国癌症研究技术有限公司 对癌症的易感性诊断及其治疗
DE69830596T2 (de) * 1997-08-26 2006-03-16 Board of Regents, The University of Texas System, Austin Ein tumorsuppressor namens ts10q23.3
US8312249B1 (en) 2008-10-10 2012-11-13 Apple Inc. Dynamic trampoline and structured code generation in a signed code environment
FR2957821B1 (fr) 2010-03-24 2014-08-29 Inst Francais Du Petrole Nouvelle zone de regeneration du catalyseur divisee en secteurs pour unites catalytiques regeneratives

Similar Documents

Publication Publication Date Title
JP2010259438A5 (enExample)
JP2009039107A5 (enExample)
DK2726635T3 (en) Multigen prognosetest for lungecancer
JP2015528295A5 (enExample)
JP2019023645A5 (enExample)
WO2015183836A1 (en) Compositions, methods, and uses related to ntrk2-tert fusions
JP2017509351A (ja) 前立腺癌遺伝子プロファイル及びその使用方法
CN102037140A (zh) Dna甲基化测定方法
US20220162710A1 (en) Composition for diagnosis or prognosis prediction of glioma, and method for providing information related thereto
CN101812537B (zh) 同时检测乙型肝炎病毒三种核苷酸类似物耐药位点的方法及其试剂盒
KR20170072685A (ko) 삼중음성유방암의 아형 분류 방법
JP2013529896A (ja) アクイフェックス・エオリカス由来の無機ピロホスファターゼの精製および使用のためのシステムおよび方法
CN109633156B (zh) 生物标志物在评估口腔鳞癌危险程度中的应用
US20200216903A1 (en) Mitochondrial Disease Genetic Diagnostics
JP2012507291A5 (enExample)
CN107630085B (zh) 分子标志物在男性骨质疏松中的应用
KR101418139B1 (ko) 넙치 성 판별용 조성물 및 성 판별 방법
KR101704533B1 (ko) 간암 바이오마커로서의 ERRγ 및 이의 용도
CN109504773B (zh) 一种与口腔鳞癌分化等级相关的生物标志物
EP1462527A1 (en) Novel markers for inflammatory bowel disease
KR101724130B1 (ko) 장 베체트병 진단용 바이오마커 및 이의 용도
CN103789436B (zh) 一种基于人工修饰引物的定量突变检测系统
KR20120031740A (ko) 위암 환자의 항암제 민감성을 예측하기 위한 키트 및 방법
US20180010103A1 (en) Methods and biomarkers for detection and treatment of langerhans cell histiocytosis
CN113881773A (zh) 一种预测甲状腺髓样癌发生淋巴结转移的标志物及其应用